Brainstem is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [1]
The brainstem is the posterior part of the brain that connects the cerebrum to the spinal cord and cerebellum. Composed of three main divisions—the midbrain (mesencephalon), pons (metencephalon), and medulla oblongata (myelencephalon)—the brainstem controls vital autonomic functions including respiration, cardiovascular regulation, and consciousness. It houses the nuclei of cranial nerves III–XII and serves as a critical relay station for ascending and descending neural pathways. The brainstem is profoundly affected in multiple neurodegenerative diseases, including ALS, Multiple System Atrophy, Progressive Supranuclear Palsy, and Parkinson's disease. [2]
The brainstem represents the evolutionary oldest portion of the brain and is essential for survival. It integrates sensory and motor information between the cerebral cortex and the spinal cord, regulates the sleep-wake cycle, and controls the autonomic nervous system. In neurodegenerative diseases, brainstem pathology can produce devastating symptoms including dysphagia, dysarthria, respiratory failure, autonomic dysfunction, and disturbances of eye movement and balance[1]. [3]
Understanding brainstem anatomy and its vulnerability to neurodegeneration is critical for diagnosing and managing conditions such as PSP (characterized by midbrain atrophy), MSA (with pontine and olivary degeneration), and ALS (with motor neuron loss in the medulla). [4]
The midbrain is the most rostral division of the brainstem, situated between the diencephalon above and the pons below. Key structures include: [5]
The pons is the middle division of the brainstem, situated between the midbrain and medulla. It serves as a major relay between the cerebral cortex and cerebellum: [6]
The medulla is the most caudal division of the brainstem, continuous with the spinal cord at the foramen magnum: [7]
The brainstem contains the cell bodies of the major modulatory neurotransmitter systems that project widely throughout the central nervous system: [8]
| Neurotransmitter | Brainstem Source | Target Regions | Disease Relevance | [9]
|-----------------|-----------------|----------------|-------------------| [10]
| dopamine | substantia nigra, ventral tegmental area | striatum, prefrontal cortex, limbic system | Parkinson's, MSA | [11]
| norepinephrine | locus coeruleus | Widespread cortical and subcortical | Alzheimer's, PSP | [12]
| serotonin | Raphe nuclei | Widespread cortical and subcortical | MSA, depression in PD | [13]
| acetylcholine | Pedunculopontine nucleus, laterodorsal tegmental nucleus | thalamus, basal ganglia | PSP, Lewy body dementia | [14]
These neuromodulatory systems are frequently and often early targets of neurodegenerative pathology, contributing to the diverse non-motor symptoms seen in these diseases[5]. [15]
Braak staging of Parkinson's disease pathology identifies the brainstem as the initial site of alpha-synuclein accumulation. In Braak stages 1–2, Lewy body pathology begins in the dorsal motor nucleus of the vagus and the olfactory bulb before ascending to the locus coeruleus and ultimately the substantia nigra in stages 3–4. This caudal-to-rostral spread supports the hypothesis that PD may begin in the peripheral autonomic nervous system and propagate to the brainstem via the vagus nerve. [16]
Brainstem involvement in parkinsons produces: [17]
PSP is a 4-repeat tauopathy with prominent brainstem pathology. The midbrain is disproportionately affected, producing the characteristic "hummingbird sign" on MRI (midbrain atrophy with preserved pons). Key brainstem features include:
Recent DTI studies have revealed impairment of the glymphatic system throughout the brainstem in PSP, suggesting that clearance dysfunction may contribute to tau accumulation. [18]
MSA is an alpha-synuclein-driven disease characterized by glial cytoplasmic inclusions (GCIs) in oligodendrocytes. The brainstem is extensively affected in both subtypes:
Recent 2026 research has identified significant serotoninergic neuronal loss in the brainstem raphe nuclei in MSA, which may contribute to sudden death in these patients. [19]
In als, degeneration of motor neurons in the brainstem produces bulbar symptoms:
While alzheimers primarily affects cortical and hippocampal regions, brainstem nuclei are also impacted:
prion-diseases such as creutzfeldt-jakob can involve the brainstem extensively, producing myoclonus, ataxia, and autonomic dysfunction. Spongiform changes, gliosis, and prion-protein deposition are found throughout the brainstem nuclei[15].
Brainstem imaging plays a crucial role in diagnosing neurodegenerative diseases:
The brainstem's involvement in neurodegenerative diseases creates both challenges and opportunities for therapeutic intervention:
deep-brain-stimulation: The pedunculopontine nucleus (PPN) is a DBS target for gait freezing in Parkinson's Disease and PSP[17].
Vagus nerve stimulation: Non-invasive vagus nerve stimulation is being explored for neuroprotection and anti-inflammatory effects via the cholinergic anti-inflammatory pathway.
Noradrenergic therapies: Pharmacological restoration of norepinephrine signaling via atomoxetine or droxidopa aims to compensate for locus-coeruleus degeneration[5].
gene-therapy: Viral vector delivery of neurotrophic factors (e.g., gdnf, neurturin) to brainstem nuclei is under investigation for Parkinson's Disease.
substantia-nigra — Midbrain structure in brainstem
thalamus — Diencephalic relay connected to brainstem
parkinsons — Disease with brainstem pathology
als — Disease affecting brainstem motor neurons
locus-coeruleus — Brainstem noradrenergic nucleus
The brainstem is extensively characterized in multiple Allen Institute atlas resources, providing valuable gene expression and cell type data for neurodegeneration research:
Allen Human Brain Atlas: The comprehensive atlas includes detailed gene expression data for all brainstem regions. Researchers can explore region-specific expression patterns for the midbrain, pons, and medulla through the Brainstem expression search. Single-nucleus RNA-seq data from the brainstem enables identification of cell type-specific molecular changes in neurodegenerative diseases[18].
Allen Mouse Brain Atlas: The mouse brainstem is comprehensively mapped with detailed anatomical annotations. The Brainstem search provides access to ISH gene expression data across development and adulthood. Mouse models of neurodegeneration often focus on brainstem nuclei (e.g., locus coeruleus, substantia nigra) making this resource essential for cross-species comparisons[19].
Allen Cell Type Atlas: Single-cell transcriptomic profiling of brainstem cell types is available through the Transcriptomic cell type reference. Key cell types profiled include dopaminergic neurons of the substantia nigra, noradrenergic neurons of the locus coeruleus, serotonergic neurons of the raphe nuclei, and various glial cell types. This atlas enables molecular characterization of cell types vulnerable in Parkinson's Disease, MSA, and other brainstem-affecting disorders[20].
BrainSpan Developmental Transcriptome: The developmental atlas provides temporal gene expression data for the brainstem across prenatal and postnatal development. The Brainstem developmental expression dataset reveals genes with stage-specific expression patterns that may inform understanding of developmental vulnerabilities and age-related neurodegeneration[21].
The study of Brainstem has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Mangold SA, Das JM. Neuroanatomy, Brainstem. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024. NCBI Bookshelf. 2024. ↩︎
Patestas MA, Gartner LP. Cranial Nerves. A Textbook of Neuroanatomy. 2016. ↩︎
Yagishita A. The Human Brainstem: Anatomy and Pathology. The Human Brainstem: Anatomy and Pathology. 2022. ↩︎
Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. Brain. 1999. ↩︎
Weinshenker D. Long road to ruin: noradrenergic dysfunction in neurodegenerative disease. Trends Neurosci. 2018. ↩︎
Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E. Staging of brain pathology related to sporadic Parkinson's Disease. Neurobiol Aging. 2003. ↩︎
Holmqvist S, Chutna O, Bousset L, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014. ↩︎
Quattrone A, et al. Brainstem and cerebellar radiological findings in Progressive Supranuclear Palsy. Brain Commun. 2025;7(1):fcaf051. Oxford Academic. 2025. ↩︎
Kovacs GG. Tauopathies. Handb Clin Neurol. 2017. ↩︎
Fanciulli A, Wenning GK. Recent advances in Multiple System Atrophy. J Neurol. 2025. Journal of Neurology. 2025. ↩︎
Metzger JM, et al. Neuroimaging in Multiple System Atrophy: clinical implications and novel developments. J Neural Transm. 2025. ↩︎
Kim H, et al. Serotonin transporter distribution in the brainstem of multiple-system atrophy–parkinsonian type. J Nucl Med. 2026 (early online). JNM. 2026. ↩︎
Neumann M, et al. Ubiquitinated tdp-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006. ↩︎
Arendt T, Brückner MK, Morawski M, Blin N, Barber R, Stichel-Gunkel CC. Early neurone loss in Alzheimer's Disease: cortical or subcortical? Acta Neuropathol Commun. Acta Neuropathol Commun. 2015. ↩︎
Budka H, Head MW, Ironside JW, Gambetti P, Parchi P, Tagliavini F. Sporadic Creutzfeldt-Jakob Disease. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. 2011. ↩︎
Keuken MC, et al. Ultra-high 7T MRI of structural age-related changes of the subthalamic nucleus. J Neurosci. 2013. ↩︎
Thevathasan W, et al. Pedunculopontine nucleus deep brain stimulation in Parkinson's Disease: a clinical review. Mov Disord. 2018. ↩︎
Allen Institute for Brain Science. Allen Mouse Brain Atlas. Brain-Map.org. ↩︎
Allen Institute for Brain Science. BrainSpan Developmental Transcriptome. BrainSpan.org. ↩︎